INTERNATIONAL PATENT: MAXYMUNE THERAPEUTICS, INC. FILES APPLICATION FOR "PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF"

GENEVA, Oct. 20 -- MAXYMUNE THERAPEUTICS, INC. (95 MAIN STREET, SUITE 9LOS ALTOS, California 94022) filed a patent application (PCT/US2025/017195) for "PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF" on Feb 25, 2025. With publication no. WO/2025/216810, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JANDELEIT, Bernd (95 MAIN STREET, SUITE 9LOS ALTOS, California 94022), GAO, Guangyao (95 MAIN STREET, SUITE 9LOS ALTOS, California 94022), FISCHER, Wolf-nicolas (95 MAIN STREET, SUITE 9LOS ALTOS, California 94022), RING...